The Prognostic Significance of Tumor Epidermal Growth Factor Receptor (EGFR) Expression Change After Neoadjuvant Chemoradiation in Patients With Rectal Adenocarcinoma

Wspolczesna Onkologia- Poland

doi 10.5114/wo.2015.50013

Full Text

Abstract

Available in

Date

Authors

Publisher

Termedia Sp. z.o.o.

Related search

The Prognostic Significance of the Expression Change of EGFR During Neoadjuvant Chemoradiotherapy in Patients With Rectal Carcinoma

2018English

Prognostic Utility of Epidermal Growth Factor Receptor (EGFR) Expression in Prostatic Acinar Adenocarcinoma

Applied Cancer Research
2019English

BRAF; Epidermal Growth Factor Receptor (EGFR)

Science-Business eXchange
2012English

Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors

Tumor Biology
MedicineCancer Research
2017English

The Role of Epidermal Growth Factor Receptor (EGFR) in the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients

Bulletin of Siberian Medicine
Molecular Medicine
2020English

KRAS Genotyping in Rectal Adenocarcinoma Specimens With Low Tumor Cellularity After Neoadjuvant Treatment

Modern Pathology
Forensic MedicinePathology
2012English

Correction To: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined With Chemotherapy Delay Brain Metastasis in Patients With EGFR‑Mutant Lung Adenocarcinoma

Targeted Oncology
Cancer ResearchOncologyPharmacology
2019English

Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer

HPB
HepatologyGastroenterology
2016English

Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis in Adenocarcinoma of Lung, the First Report From Iran

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy